195 related articles for article (PubMed ID: 25619396)
1. Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.
Li TT; Zhang XH; Jing JF; Li X; Yang XQ; Zhu FH; Tang W; Zuo JP
Acta Pharmacol Sin; 2015 Feb; 36(2):188-99. PubMed ID: 25619396
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
[TBL] [Abstract][Full Text] [Related]
3. Betulinic acid, isolated from the leaves of Syzygium cumini (L.) Skeels, ameliorates the proteinuria in experimental membranous nephropathy through regulating Nrf2/NF-κB pathways.
Sutariya B; Taneja N; Saraf M
Chem Biol Interact; 2017 Aug; 274():124-137. PubMed ID: 28711658
[TBL] [Abstract][Full Text] [Related]
4. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Improves the Renal Autophagy in Rat Experimental Membranous Nephropathy via Regulating the PI3K/AKT/mTOR and Nrf2/HO-1 Signaling Pathways.
Di Tu Q; Jin J; Hu X; Ren Y; Zhao L; He Q
Biomed Res Int; 2020; 2020():7069052. PubMed ID: 33204708
[TBL] [Abstract][Full Text] [Related]
6. Crocin improves the renal autophagy in rat experimental membranous nephropathy via regulating the SIRT1/Nrf2/HO-1 signaling pathway.
Liu H; Cheng H; Wang H; Wang Q; Yuan J
Ren Fail; 2023; 45(2):2253924. PubMed ID: 37724538
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with DHA and BMSCs suppressed podocyte injury and attenuated renal fibrosis by modulating the TGF-
Li Y; Chen S; Tan J; Zhou Y; Ren M; Zhang Q; Zhao M; Yuan G; Zhang W; Yang F
Ren Fail; 2023 Dec; 45(1):2120821. PubMed ID: 36648018
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy.
Stratakis S; Stylianou K; Petrakis I; Mavroeidi V; Poulidaki R; Petra C; Moisiadis D; Stratigis S; Vardaki E; Nakopoulou L; Daphnis E
Clin Dev Immunol; 2013; 2013():941893. PubMed ID: 24069045
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
[TBL] [Abstract][Full Text] [Related]
10. A new role for complement in experimental membranous nephropathy in rats.
Salant DJ; Belok S; Madaio MP; Couser WG
J Clin Invest; 1980 Dec; 66(6):1339-50. PubMed ID: 7440718
[TBL] [Abstract][Full Text] [Related]
11. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
[TBL] [Abstract][Full Text] [Related]
12. Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGFβ1-smad signaling.
Han Y; Lu JS; Xu Y; Zhang L; Hong BF
Int J Clin Exp Pathol; 2015; 8(5):4725-34. PubMed ID: 26191162
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
[TBL] [Abstract][Full Text] [Related]
16. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
17. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
[TBL] [Abstract][Full Text] [Related]
18. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
19. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
20. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
